First Header Logo Second Header Logo


Kathleen Hayden to Antihypertensive Agents

This is a "connection" page, showing publications Kathleen Hayden has written about Antihypertensive Agents.
Connection Strength

  1. Chuang YF, Breitner JCS, Chiu YL, Khachaturian A, Hayden K, Corcoran C, Tschanz J, Norton M, Munger R, Welsh-Bohmer K, Zandi PP. Use of diuretics is associated with reduced risk of Alzheimer's disease: the Cache County Study. Neurobiol Aging. 2014 Nov; 35(11):2429-2435.
    View in: PubMed
    Score: 0.098
  2. Khachaturian AS, Zandi PP, Lyketsos CG, Hayden KM, Skoog I, Norton MC, Tschanz JT, Mayer LS, Welsh-Bohmer KA, Breitner JC. Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. Arch Neurol. 2006 May; 63(5):686-92.
    View in: PubMed
    Score: 0.056
  3. Wharton W, Anderson A, Hayden KM, Carmichael OT, Clark JM, Luchsinger JA, Espeland M, Yasar S. Effect of renin-angiotensin system antihypertensive medication use on cognitive function in diabetes mellitus with obesity or overweight: An ancillary study to the Action for Health in Diabetes (Look AHEAD) trial. Diabetes Obes Metab. 2022 Dec; 24(12):2443-2453.
    View in: PubMed
    Score: 0.044
  4. Corrada MM, Hayden KM, Paganini-Hill A, Bullain SS, DeMoss J, Aguirre C, Brookmeyer R, Kawas CH. Age of onset of hypertension and risk of dementia in the oldest-old: TheĀ 90+ Study. Alzheimers Dement. 2017 02; 13(2):103-110.
    View in: PubMed
    Score: 0.030
  5. Mielke MM, Rosenberg PB, Tschanz J, Cook L, Corcoran C, Hayden KM, Norton M, Rabins PV, Green RC, Welsh-Bohmer KA, Breitner JC, Munger R, Lyketsos CG. Vascular factors predict rate of progression in Alzheimer disease. Neurology. 2007 Nov 6; 69(19):1850-8.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.